NSUN3 demonstrated no differences in bladder urothelial carcinoma (BLCA), cervical squamous cell carcinoma, and endocervical adenocarcinoma (CESC), DLBCL, KICH, KIRC, KIRP, MESO, PCPG, prostate adenocarcinoma (PRAD), SARC, thyroid carcinoma (THCA), and UVM, or <3 cases in normal tissues. This evidence concerns the gene NSUN3 and prostate adenocarcinoma.